Omada Health, Inc. Selling and Marketing Expense
Omada Health, Inc. (OMDA) reported Selling and Marketing Expense of $29.89 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:SellingAndMarketingExpense · last filed 2026-08-07
- Omada Health, Inc. selling and marketing expense for the quarter ending 2026-06-30 was $29.89M, a 33.92% increase year-over-year.
- Omada Health, Inc. selling and marketing expense for the quarter ending 2026-03-31 was $26.79M, a 32.81% increase year-over-year.
- Omada Health, Inc. selling and marketing expense for the quarter ending 2025-12-31 was $24.61M, a 36.07% increase year-over-year.
- Omada Health, Inc. selling and marketing expense for the quarter ending 2025-09-30 was $22.94M, a 30.53% increase year-over-year.
- Omada Health, Inc. selling and marketing expense for fiscal 2025 was $90.04M, a 32.31% increase from fiscal 2024.
- Omada Health, Inc. selling and marketing expense for fiscal 2024 was $68.05M, a 2.72% increase from fiscal 2023.
- Omada Health, Inc. selling and marketing expense for fiscal 2023 was $66.25M.
| Period end | Selling and Marketing Expense 3 month | Selling and Marketing Expense 6 month | Selling and Marketing Expense 9 month | Selling and Marketing Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $29.89M 10-Q · filed 2026-08-07 | $56.67M 10-Q · filed 2026-08-07 | $81.29M derived: sum of 3 quarters · filed 2026-08-07 | $104.23M derived: sum of 4 quarters · filed 2026-08-07 |
| 2026-03-31 | $26.79M 10-Q · filed 2026-05-08 | $51.40M derived: sum of 2 quarters · filed 2026-05-08 | $74.34M derived: sum of 3 quarters · filed 2026-05-08 | $96.66M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-12-31 | $24.61M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-06 | $47.56M derived: sum of 2 quarters · filed 2026-03-06 | $69.87M derived: sum of 3 quarters · filed 2026-08-07 | $90.04M 10-K · filed 2026-03-06 |
| 2025-09-30 | $22.94M 10-Q · filed 2025-11-07 | $45.26M derived: sum of 2 quarters · filed 2026-08-07 | $65.43M 10-Q · filed 2025-11-07 | $83.52M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-06-30 | $22.32M 10-Q · filed 2026-08-07 | $42.49M 10-Q · filed 2026-08-07 | $60.58M derived: sum of 3 quarters · filed 2026-08-07 | $78.15M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-03-31 | $20.17M 10-Q · filed 2026-05-08 | $38.26M derived: sum of 2 quarters · filed 2026-05-08 | $55.84M derived: sum of 3 quarters · filed 2026-05-08 | $71.03M derived: sum of 4 quarters · filed 2026-05-08 |
| 2024-12-31 | $18.09M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-06 | $35.67M derived: sum of 2 quarters · filed 2026-03-06 | $50.86M derived: sum of 3 quarters · filed 2026-03-06 | $68.05M 10-K · filed 2026-03-06 |
| 2024-09-30 | $17.58M 10-Q · filed 2025-11-07 | $32.77M derived: sum of 2 quarters · filed 2025-11-07 | $49.96M 10-Q · filed 2025-11-07 | |
| 2024-06-30 | $15.19M 10-Q · filed 2025-08-08 | $32.39M 10-Q · filed 2025-08-08 | ||
| 2023-12-31 | $66.25M 10-K · filed 2026-03-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B | ||
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |